how long do glp-1 stay in your system Does a Injection Last System? Why GLP-1 Microdosing? A Closer

Studies with PYY agonists administered intravenously have shown reduction in food intake with increased satiety [92, 93], however, a nasal PYY agonist showed minimal efficacy with poor tolerability [94]

GLP-1 drugs have been approved for the treatment of diabetes and obesity, meaning that the FDA has determined that for people with these disorders, the benefits of taking the drug outweigh the potential risks

That said, side effects are still generally manageable and tend to improve with time and proper dosing

Conditions under active investigation include prediabetes, heart failure with preserved ejection fraction, obstructive sleep apnoea, knee osteoarthritis, polycystic ovarian syndrome, and inflammatory bowel disease